Barclays’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.74M | Buy |
273,912
+82,675
| +43% | +$1.43M | ﹤0.01% | 1665 |
|
|
2025
Q1 | $4.18M | Buy |
191,237
+31,672
| +20% | +$693K | ﹤0.01% | 1532 |
|
|
2024
Q4 | $5.09M | Sell |
159,565
-96,332
| -38% | -$3.07M | ﹤0.01% | 1594 |
|
|
2024
Q3 | $7.38M | Buy |
255,897
+39,019
| +18% | +$1.13M | ﹤0.01% | 1221 |
|
|
2024
Q2 | $8.32M | Buy |
216,878
+191,086
| +741% | +$7.33M | ﹤0.01% | 969 |
|
|
2024
Q1 | $1.52M | Sell |
25,792
-170,599
| -87% | -$10M | ﹤0.01% | 2123 |
|
|
2023
Q4 | $11.8M | Sell |
196,391
-146,498
| -43% | -$8.77M | ﹤0.01% | 962 |
|
|
2023
Q3 | $13M | Buy |
342,889
+30,659
| +10% | +$1.17M | 0.01% | 789 |
|
|
2023
Q2 | $28.4M | Buy |
312,230
+70,049
| +29% | +$6.38M | 0.02% | 581 |
|
|
2023
Q1 | $16M | Buy |
242,181
+14,834
| +7% | +$978K | 0.01% | 665 |
|
|
2022
Q4 | $11.8M | Buy |
227,347
+94,198
| +71% | +$4.87M | 0.01% | 785 |
|
|
2022
Q3 | $9.1M | Buy |
133,149
+109,713
| +468% | +$7.49M | 0.01% | 848 |
|
|
2022
Q2 | $1.06M | Sell |
23,436
-29,168
| -55% | -$1.32M | ﹤0.01% | 2020 |
|
|
2022
Q1 | $2.67M | Sell |
52,604
-92,644
| -64% | -$4.71M | ﹤0.01% | 1569 |
|
|
2021
Q4 | $6.87M | Buy |
145,248
+112,555
| +344% | +$5.32M | ﹤0.01% | 1064 |
|
|
2021
Q3 | $1.08M | Sell |
32,693
-4,426
| -12% | -$146K | ﹤0.01% | 2215 |
|
|
2021
Q2 | $2.35M | Sell |
37,119
-54,915
| -60% | -$3.47M | ﹤0.01% | 1627 |
|
|
2021
Q1 | $3.95M | Buy |
92,034
+3,404
| +4% | +$146K | ﹤0.01% | 1363 |
|
|
2020
Q4 | $5.07M | Sell |
88,630
-72,188
| -45% | -$4.13M | ﹤0.01% | 1020 |
|
|
2020
Q3 | $4.85M | Buy |
160,818
+97,314
| +153% | +$2.94M | ﹤0.01% | 990 |
|
|
2020
Q2 | $2.07M | Sell |
63,504
-126,534
| -67% | -$4.13M | ﹤0.01% | 1447 |
|
|
2020
Q1 | $5.09M | Sell |
190,038
-970,396
| -84% | -$26M | ﹤0.01% | 866 |
|
|
2019
Q4 | $35.5M | Buy |
1,160,434
+1,113,185
| +2,356% | +$34.1M | 0.02% | 437 |
|
|
2019
Q3 | $1.14M | Sell |
47,249
-71,889
| -60% | -$1.73M | ﹤0.01% | 2174 |
|
|
2019
Q2 | $3.02M | Buy |
119,138
+39,983
| +51% | +$1.01M | ﹤0.01% | 1466 |
|
|
2019
Q1 | $1.54M | Buy |
79,155
+77,574
| +4,907% | +$1.51M | ﹤0.01% | 1782 |
|
|
2018
Q4 | $21K | Sell |
1,581
-12,473
| -89% | -$166K | ﹤0.01% | 3366 |
|
|
2018
Q3 | $251K | Buy |
14,054
+11,406
| +431% | +$204K | ﹤0.01% | 2962 |
|
|
2018
Q2 | $58K | Buy |
2,648
+281
| +12% | +$6.16K | ﹤0.01% | 3251 |
|
|
2018
Q1 | $53K | Buy |
2,367
+650
| +38% | +$14.6K | ﹤0.01% | 3484 |
|
|
2017
Q4 | $37K | Buy |
+1,717
| New | +$37K | ﹤0.01% | 3459 |
|